NS

Nilam Sandip Patil

Active Director Designated Partner DIN 11210447
DIN 11210447 First appointment Jul 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Nilam Sandip Patil

Data last updated:

Nilam Sandip Patil is a Designated Partner at Family Pharmacy (Bhogavati) Llp (since 2025).

DIN 11210447
Primary Designation Designated Partner
First Appointment 24 Jul 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner24 Jul 20252025Active

Board colleagues of Nilam Sandip Patil

NameDINCompanyDesignation
Siddhee Vinayak Patil11210445Family Pharmacy (Bhogavati) LlpDesignated Partner
Snehal Rohit Teli11210446Family Pharmacy (Bhogavati) LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Family Pharmacy (Bhogavati) Llp
Premium access

Shareholding and investment profile for Nilam Sandip Patil

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nilam Sandip Patil

Nilam Sandip Patil currently holds 1 directorship: Family Pharmacy (Bhogavati) Llp (Designated Partner, since 24 Jul 2025).

Nilam Sandip Patil was first appointed on 24 Jul 2025 as Designated Partner at Family Pharmacy (Bhogavati) Llp.

The current boards of Nilam Sandip Patil's companies include Siddhee Vinayak Patil (Family Pharmacy (Bhogavati) Llp), Snehal Rohit Teli (Family Pharmacy (Bhogavati) Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available